Journal ArticleDOI
Abnormal night vision with isotretinoin therapy for acne.
Reads0
Chats0
TLDR
A 19-year-old trainee RAF navigator who developed abnormal night vision during isotretinoin therapy, given in a dose of 70 mg daily for acne vulgaris, complained of blurred vision, photophobia and decreased night vision, and electrophysiology showed little recovery in retinal function.Abstract:
SIR, we would like to report a case of a 19-year-old trainee RAF navigator who developed abnormal night vision during isotretinoin therapy, given in a dose of 70 mg daily for acne vulgaris. He developed the common side-effects of dry skin and cheilitis, but after 3 weeks of treatment he complained of blurred vision, photophobia and decreased night vision. His visual acuities were reduced to 6/18 in the right eye and 6/12 in the left eye. Refraction showed 1-5 dioptres of myopia in both eyes but appropriate correction of this produced 6/4 vision in both eyes. Blepharoconjunctivitis was noted bilaterally but otherwise ocular examination was unremarkable, and in particular both fundi and optic discs were normal. There was no family history or ophthalmic evidence of retinitis pigmentosa. Isotretinoin therapy was withdrawn immediately and the decreased night vision was investigated using electrophysiology. Visual evoked potentials (VEP) were normal but the scotopic electro-retinogram (ERG) and the electro-oculogram (EOG) were abnormal, suggesting poor retinal function in dark adapted conditions. At 2 weeks followup his unaided vision had returned to normal with no significant refractive error. However, at 3 months follow-up the patient still complained of poor night vision and the ERG and EOG showed little recovery in retinal function. At the last follow-up appointment, 9 months after withdrawal of isotretinoin, the patient subjectively felt that his night vision was still poor.read more
Citations
More filters
Journal ArticleDOI
Ocular side effects possibly associated with isotretinoin usage
TL;DR: Adverse ocular side effects secondary to isotretinoin that are "certain" include abnormal meibomian gland secretion, blepharoconjunctivitis, corneal opacities, decreased dark adaptation, decreased tolerance to contact lens, decreased vision, increased tear osmolarity, keratitis, and teratogenic ocular abnormalities.
Journal ArticleDOI
Preventing and managing the side effects of isotretinoin.
TL;DR: Both the most common and the most concerning side effects are examined as well as ways in which providers and patients may best manage them to be able to benefit from isotretinoin treatment.
Journal ArticleDOI
Safety issues in isotretinoin therapy.
Nathan Hanson,Sancy A. Leachman +1 more
TL;DR: The most common adverse effects observed during treatment are mucocutaneous and ocular in nature, but laboratory abnormalities and effects in the nervous, musculoskeletal, gastrointestinal, pulmonary, hematologic, and other systems are also described.
Journal ArticleDOI
Comparison of dose-related ocular side effects during systemic isotretinoin administration.
TL;DR: During systemic isotretinoin treatment, eye dryness was related to the dose used, at least during the period of treatment, and the rate of conjunctival S aureus colonization was unrelated to the doses used.
Journal ArticleDOI
Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero.
TL;DR: This paper will review and put in perspective the issues important to consider in the proper use of isotretinoin and show how this wonder drug's continued availability depends upon its responsible and informed use.
References
More filters
Journal ArticleDOI
Adverse ocular reactions possibly associated with isotretinoin.
TL;DR: A total of 261 adverse ocular reactions occurred in 237 patients who received isotretinoin, a commonly used drug in the treatment of severe cystic acne, and the number of cases of decreased dark adaptation are under investigation.
Journal ArticleDOI
Visual toxicity of synthetic retinoids.
R. D. Brown,C. E. H. Grattan +1 more
TL;DR: Significant falls occurred in the amplitude of the a waves of the scotopic electroretinogram in patients treated with isotretinoin, a synthetic vitamin A analogue.